跳至主要内容
临床试验/ACTRN12622000621718
ACTRN12622000621718招募中未知

PRAETORIAN: Prospective Registry for geniculate Arterial Embolisation as Treatment for OsteoaRthrItis And Neovascularity

I-MED Radiology Network0 个研究点目标入组 150 人开始时间: 2022年4月27日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
40 Years 至 o limit(—)
性别
All

入选标准

  • Inclusion criteria for group A (patients with moderate-to-severe chronic pain following TKA):
  • -Age 40 yrs or older who are willing and able to provide informed consent
  • -Experiencing ongoing moderate to severe pain for at least 6 months after total knee arthroplasty
  • - and having failed conservative medical treatment for at least 6 months (e.g. physiotherapy/anti-inflammatory/analgesia/masso-kinesiotherapy, etc.)
  • Inclusion criteria for group B (patients with moderate-to-severe KOA):
  • -Age 40 yrs or older who are willing and able to provide informed consent
  • -Presence of moderate to severe knee OA as stipulated by referring orthopedic surgeon
  • -Presence of knee pain for at least 6 months, resistant to conservative treatments (e.g. physiotherapy, analgesia, exercise, weight loss, intra-articular injections, etc.)
  • -Non-surgical candidates: ineligible/refused total knee arthroplasty (TKA)

排除标准

  • Exclusion criteria for group A (patients with moderate-to-severe chronic pain following TKA):
  • -Rheumatoid, infectious arthritis, osteonecrosis, or advanced atherosclerosis
  • -Malignancy
  • -Renal impairment (eGFR <45)
  • -A bleeding diathesis
  • -Irreversible coagulopathy
  • -Re-operation
  • -Allergic to contrast media
  • Exclusion criteria for group B (patients with moderate-to-severe KOA):
  • -Rheumatoid, infectious arthritis, osteonecrosis, or advanced atherosclerosis
  • -Malignancy
  • -Renal impairment (eGFR <45)
  • -A bleeding diathesis
  • -Irreversible coagulopathy
  • -Allergic to contrast media

研究者

发起方
I-MED Radiology Network

相似试验

招募中
不适用
on-interventional, Prospective register concerning treatment of cervical cancer FIGO IB - IIA by nerve-sparing total mesometrial resection and therapeutic lymphadenectomy (TMMR/tLNE) according to M. Hoeckel.C53Malignant neoplasm of cervix uteri
DRKS00004793niversitätsklinikum Essen300
招募中
不适用
Evaluation of the Impact of Fractional flow reserve and Optical Coherence Tomography on the Outcomes of Percutaneous coronary intervention in Diabetic Patients
CTRI/2021/09/036375Ananthapuri Hospitals and Research Institute
招募中
不适用
Prospective and Non-interventional registry to Investigate Effectiveness and Safety of Rivaroxaban on Prevention of Stroke and Systemic Embolism in Patients with Non-valvular Atrial Fibrillation at Fukui Red Cross Hospitalon-valvular atrial fibrillation (In the present study, non-valvular atrial fibrillation refers to atrial fibrillation without a history of prosthetic valve replacement or mitral valve stenosis.)
JPRN-UMIN000017523Fukui Red Cross Hospital100
招募中
不适用
Prospective registry to evaluate the value of the local microbiome in the context of adhesive capsulitis, periprosthetic joint infection, and other chronic and chronic inflammatory diseases of the musculoskeletal systemM75.0T84.9Adhesive capsulitis of shoulderUnspecified complication of internal orthopaedic prosthetic device, implant and graft
DRKS00028928Klinikum der Universität München, Campus Großhadern100
招募中
3 期
A Confirmatory, Prospective, Open-label, Single-arm, Reader-blinded Multi-centre Phase 3 Study to Assess the Diagnostic Accuracy of Ferumoxtran-10-enhanced Magnetic Resonance Imaging (MRI) and Unenhanced MRI in Reference to Histopathology in Newly-diagnosed Prostate Cancer (PCA) Patients, Scheduled for Radical Prostatectomy (RP) With Extended Pelvic Lymph Node Dissection (ePLND).metastasised lymph nodes in the pelvic regionhigh risk prostate cancerC61Malignant neoplasm of prostate
DRKS00019106Saving Patients' Lives Medical B.V. (SPL Medical)200